Ticker > Company >

Everest Organics share price

Everest Organics Ltd.

BSE: 524790 SECTOR: Pharmaceuticals & Drugs  21k   169   10

270.35
0 0
BSE: 20 Dec 04:01 PM

Price Summary

Today's High

₹ 270.35

Today's Low

₹ 270.35

52 Week High

₹ 270.35

52 Week Low

₹ 110

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

216.28 Cr.

Enterprise Value

273.24 Cr.

No. of Shares

0.8 Cr.

P/E

0

P/B

5.34

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  50.61

CASH

0.83 Cr.

DEBT

57.79 Cr.

Promoter Holding

74.15 %

EPS (TTM)

₹  -6.59

Sales Growth

7.75%

ROE

0.3 %

ROCE

6.03%

Profit Growth

176.4 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.75%
3 Year2.8%
5 Year4.82%

Profit Growth

1 Year176.4%
3 Year-78.35%
5 Year-54.96%

ROE%

1 Year0.3%
3 Year0.79%
5 Year14.51%

ROCE %

1 Year6.03%
3 Year5.33%
5 Year16.99%

Debt/Equity

1.2607

Price to Cash Flow

13.17

Interest Cover Ratio

1.1117

CFO/PAT (5 Yr. Avg.)

2.79314783356351

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 74.15 0.00
Jun 2024 74.15 0.00
Mar 2024 74.15 0.00
Dec 2023 74.15 0.00
Sep 2023 74.15 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -87.8255 days.
  • The company has a high promoter holding of 74.15%.

 Limitations

  • The company has shown a poor profit growth of -78.3488414114868% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.79853827395913% for the Past 3 years.
  • Company has a poor ROE of 0.786784147900473% over the past 3 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 41.5655.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 49.45 52.51 52.62 32.45 44.05
Total Expenditure 46.74 49.71 49.66 36.1 40.62
Operating Profit 2.71 2.8 2.96 -3.66 3.43
Other Income 0.24 0.13 0.3 0.33 0.14
Interest 1.49 1.45 1.24 1.29 1.35
Depreciation 1.32 1.33 1.85 1.47 1.47
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.14 0.15 0.16 -6.09 0.75
Tax 0.11 0.14 0.1 0 0.01
Profit After Tax 0.03 0.02 0.06 -6.09 0.74
Adjusted EPS (Rs) 0.04 0.02 0.07 -7.61 0.93

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 167.21 181.57 200.05 183.05 197.24
Total Expenditure 147.93 158.72 193.62 182.12 186.25
Operating Profit 19.28 22.84 6.43 0.93 10.99
Other Income 1.45 1.06 2.21 6.94 0.89
Interest 3.43 3.26 3.1 3.31 5.47
Depreciation 3.21 3.37 3.8 4.47 5.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.09 17.27 1.74 0.09 0.61
Tax 3.2 3.56 0.6 0.27 0.47
Net Profit 10.9 13.72 1.14 -0.18 0.14
Adjusted EPS (Rs.) 13.62 17.14 1.43 -0.23 0.17

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8 8 8 8 8
Total Reserves 26.2 38.58 38.8 38.21 37.84
Borrowings 4.61 5.81 10.99 12.28 14.64
Other N/C liabilities 7.47 5.63 7.66 5.78 6.14
Current liabilities 74.01 77.36 112.56 137.58 160.1
Total Liabilities 120.29 135.38 178 201.85 226.72
Assets
Net Block 39.04 43.57 48.97 54.47 52.33
Capital WIP 1.13 0.08 8.03 9.49 19.35
Intangible WIP 0 0 0 2.1 1.68
Investments 0.08 0.08 0.08 0.08 0.08
Loans & Advances 0.91 2.4 3.04 3.23 3.3
Other N/C Assets 0 0 0 0 0
Current Assets 79.14 89.25 117.88 132.48 149.98
Total Assets 120.29 135.38 178 201.85 226.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 14.09 13.72 1.14 -0.18 0.14
Adjustment 3.51 6.38 6.72 7.75 10.65
Changes in Assets & Liabilities -7.89 -6.56 5.87 10.85 5.63
Tax Paid 0 0 0 0 0
Operating Cash Flow 9.71 13.53 13.74 18.42 16.42
Investing Cash Flow -6.31 -11.82 -16.82 -16.15 -13.32
Financing Cash Flow -3.36 -2.05 2.07 -2.64 -3.1
Net Cash Flow 0.04 -0.34 -1.01 -0.38 0

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 74.15 74.15 74.15 74.15 74.15
bk advance research llp 2.80 2.80 2.80 2.80 2.80
hari krishna sk 0.07 0.07 0.07 0.07 0.07
kakarlapudi raju sitarama... 1.42 1.42 1.42 1.42 1.42
nadimpalli v raju 1.41 1.41 1.41 1.41 1.41
rajagopal rao rangineni 0.70 0.70 0.70 0.70 0.70
sk g parvathi 0.40 0.40 0.40 0.40 0.40
sri kakarlapudi krishna v... 3.94 3.94 3.94 3.94 3.94
sri kakarlapudi sirisha 1.35 1.35 1.35 1.35 1.35
sri kakarlapudi sri hari ... 15.49 15.49 15.49 15.49 15.49
veerat finance & investme... 46.57 46.57 46.57 46.57 46.57
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 25.85 25.85 25.85 25.85 25.85
everest organics limited ... 2.26 2.26 2.26 2.26 2.26

Ratings & Research Reports

Company Presentations

Company News

Everest Organics informs about cancellation of board meeting 9 Dec, 5:21 PM Everest Organics informs about board meeting 7 Dec, 3:06 PM Everest Organics informs about resignation of independent director 4 Dec, 4:55 PM Everest Organics informs about retirement of non-executive director 4 Oct, 4:48 PM Everest Organics - Quaterly Results 13 Aug, 3:55 PM Everest Organics - Quaterly Results 13 Aug, 3:55 PM Everest Organics informs about board meeting 8 Aug, 9:49 AM Everest Organics - Quaterly Results 27 May, 7:07 PM Everest Organics - Quaterly Results 27 May, 7:07 PM Everest Organics - Quaterly Results 9 Feb, 3:33 PM Everest Organics - Quaterly Results 9 Feb, 3:33 PM Everest Organics - Quaterly Results 9 Feb, 3:33 PM Everest Organics informs about details of loss of certificate 25 Jan, 4:35 PM Everest Organics informs about press release 13 Nov, 1:52 PM Everest Organics informs about credit rating 24 Aug, 4:20 PM Everest Organics informs about press release 17 Aug, 12:39 PM Everest Organics informs about certificate 7 Jul, 5:40 PM Everest Organics informs about compliances-certificate 5 Apr, 4:51 PM Everest Organics - Quaterly Results 14 Feb, 3:19 PM Everest Organics informs about disclosure on related party transactions 18 Nov, 5:07 PM Everest Organics - Quaterly Results 11 Nov, 1:21 PM Everest Organics informs about board meeting 3 Nov, 4:17 PM Everest Organics informs about compliance certificate 6 Oct, 12:38 PM Everest Organics informs about annual report 2 Sep, 4:09 PM Everest Organics informs about AGM 2 Sep, 4:00 PM Everest Organics - Quaterly Results 9 Aug, 2:09 PM Everest Organics - Quaterly Results 9 Aug, 2:09 PM Everest Organics - Quaterly Results 9 Aug, 2:09 PM Everest Organics informs about loss of share certificate 21 Jul, 2:02 PM Everest Organics informs about demises of MD 27 Apr, 5:15 PM Everest Organics informs about loss of share certificates 14 Mar, 5:17 PM Everest Organics informs about disclosure 2 Mar, 4:42 PM Everest Organics informs about newspaper publication 5 Feb, 3:39 PM Everest Organics informs about compliance certificate 5 Jan, 4:14 PM Everest Organics informs about press release 12 Oct, 4:52 PM Everest Organics develops new API to treat Covid-19 12 Oct, 12:57 PM Everest Organics submits share transfer audit certificate 6 Oct, 5:00 PM Everest Organics informs about issuance of duplicate share certificate 17 Sep, 5:19 PM Everest Organics informs about issuance of duplicate share certificate 18 Aug, 10:48 AM Everest Organics informs about newspaper advertisements 13 Aug, 3:38 PM Everest Organics informs about newspaper publication 5 Jun, 2:11 PM Everest Organics develops anti-fungal API ‘Posaconazole’ 25 May, 9:55 AM Everest Organics informs about compliance certificate 5 Apr, 4:12 PM Everest Organics informs about disclosure 19 Feb, 11:49 AM Everest Organics board approves unaudited financial results 8 Feb, 4:12 PM Everest Organics receives temporary closure orders for Telangana unit 8 Jan, 10:58 AM Everest Organics informs about loss of share certificate 23 Dec, 4:09 PM Everest Organics informs about loss of share certificate 22 Sep, 3:18 PM Everest Organics develops Remdesivir API 10 Aug, 12:24 PM Everest Organics informs about board meeting 18 Jun, 3:32 PM

Everest Organics Stock Price Analysis and Quick Research Report. Is Everest Organics an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Everest Organics and its performance over the period of time. Everest Organics stock price today is Rs 270.35.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Everest Organics cash from the operating activity was Rs 16.4201 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Everest Organics has a Debt to Equity ratio of 1.2607 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Everest Organics , the EPS growth was 176.3828 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Everest Organics has OPM of 5.57013161036761 % which is a bad sign for profitability.
     
  • ROE: Everest Organics have a poor ROE of 0.3024 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Everest Organics is Rs 270.35. One can use valuation calculators of ticker to know if Everest Organics share price is undervalued or overvalued.
Last Updated on:
Brief about Everest Organics
X